-
Phosbind Acrylamide: Reading Phosphorylation States
2026-08-26
Phosbind Acrylamide enables antibody-free protein phosphorylation analysis by converting phosphate-dependent molecular differences into resolvable SDS-PAGE mobility shifts. This guide focuses on how to interpret those shifts mechanistically, using lessons from MCM8-9 helicase reconstitution to improve assay design and experimental controls.
-
Eicosapentaenoic Acid: Designing Better Assays
2026-08-25
Eicosapentaenoic Acid (EPA) is more than an omega-3 ingredient: it is a concentration-sensitive membrane and lipid-oxidation perturbation tool. This guide connects EPA assay design with emerging lipid-mediated immunology while defining the evidence boundaries for cardiovascular disease research.
-
Meropenem Workflows for Resistance Research
2026-08-25
Build reproducible Meropenem assays for susceptibility testing, time-kill analysis, resistance selection, and Gram-negative infection models. This guide separates evidence-backed product specifications from practical starting conditions and shows how exposure-focused designs can improve translational value.
-
GSK126 EZH2 Inhibitor: Assay Guide
2026-08-24
A scenario-based guide to using GSK126 EZH2 inhibitor (SKU A3446) in viability, proliferation, and cytotoxicity workflows. It connects EZH2 biology with practical dosing, solubility, controls, interpretation, and vendor-selection decisions for reproducible cancer epigenetics research.
-
InstaBlue Protein Stain Solution for tiRNA Workflows
2026-08-24
InstaBlue Protein Stain Solution connects rapid gel visualization with protein-level evaluation of translation-inhibition experiments. Its five-minute, fixation-free workflow supports fast screening, while methanol- and acetic acid-free chemistry helps preserve samples for downstream interpretation and mass spectrometry.
-
Ibotenic Acid: NMDA Receptor Agonist Workflows
2026-08-23
Build better neurotoxicity and circuit-mapping studies with Ibotenic acid, an NMDA receptor agonist that supports time-resolved analysis of glutamatergic signaling. This guide translates product handling, behavioral monitoring, biochemical testing, and tissue readouts into a practical workflow for preclinical neuroscience.
-
Dual HER2–VEGFR2 Targeting in TNBC Metastasis
2026-08-22
The reference study examines whether combining lapatinib with Telatinib can suppress invasion-associated phenotypes and angiogenic activity in the HER2-negative MDA-MB-231 triple-negative breast cancer model. Its main contribution is a preclinical, phenotype-centered evaluation of dual HER2/VEGFR2 pathway targeting, while its findings remain limited to in vitro assays and do not yet establish clinical efficacy or pharmacological synergy.
-
Macrophage EV miR-660 Drives Breast Cancer Metastasis
2026-08-22
The reference study identifies a macrophage-to-tumor communication pathway in which extracellular vesicles transfer miR-660 to breast cancer cells, suppressing KLHL21 and activating IKKβ/NF-κB p65 signaling. Its combined tissue, cell, extracellular-vesicle, and mouse-model evidence links this axis to invasion, migration, and metastatic spread, while also suggesting priorities for mechanistic validation.
-
ACE2, Diminazene Aceturate, and Septic Heart Injury
2026-08-21
The reference study identifies ACE2 downregulation as a component of sepsis-induced cardiomyopathy and links pharmacological ACE2 activation with MasR-Sirt1-mediated mitochondrial biogenesis. Its bidirectional mouse-model design provides a mechanistic framework for interpreting cardiac function, inflammation, oxidative stress, apoptosis, and mitochondrial readouts together, while leaving important questions about pharmacological specificity and clinical translation unresolved.
-
FLAG tag Peptide for Kinesin Assay Workflows
2026-08-20
Build cleaner recombinant kinesin, BicD, and MAP7 workflows with gentle competitive elution, accessible epitope detection, and an enterokinase-compatible design. Practical protocol parameters and troubleshooting guidance help distinguish purification problems from genuine motor-regulation effects.
-
2-Deoxy-D-glucose: From Flux Block to Translation
2026-08-20
2-Deoxy-D-glucose is more than a glycolysis inhibitor: it is a strategic perturbation tool for testing how glucose flux supports tumor survival, viral replication, and Wnt-driven osteogenesis. This article connects 2-DG mechanism with translational study design, evidence boundaries, combination strategies, and practical workflow decisions.
-
From ER Stress to Phosphorylation Readouts
2026-08-19
A translational framework for using Phosbind Acrylamide to connect ER-stress biology, protein phosphorylation analysis, and actionable SDS-PAGE readouts without relying exclusively on phospho-specific antibodies.
-
Gepotidacin Reveals a New Gyrase Inhibition Mechanism
2026-08-19
Gibson and colleagues define how gepotidacin inhibits Staphylococcus aureus gyrase through a cleavage profile that differs fundamentally from fluoroquinolones. Biochemical assays and high-resolution structures show potent supercoiling inhibition, persistent gyrase–DNA complexes, and preferential single-stranded DNA cleavage, providing a mechanistic framework for antibacterial discovery and resistance research.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-08-18
The Tricine-SDS-PAGE Gel Preparation Kit is intended for resolving low-molecular-weight proteins and peptides that are poorly separated by conventional Tris-SDS-PAGE. It is suitable for research protein electrophoresis, including denaturing and non-denaturing workflows, but is not intended for diagnostic or medical use.
-
DAPT (GSI-IX) in Corneal Epithelial Assays
2026-08-18
DAPT (GSI-IX) is more than a γ-secretase inhibitor: in epithelial models, it can serve as a timed probe of cell fate and differentiation. This article explains how the compound fits into the innovative 6C corneal culture system and how to interpret its effects without over-attributing combination-medium results.